Social networks
2,459Activities
Technologies
Entity types
Location
Hemmelrather Weg 201, 51377 Leverkusen, Germany
Leverkusen
Germany
Employees
Scale: 51-200
Estimated: 83
Engaged corporates
0Added in Motherbase
2 months, 1 week agoWe aim to protect and heal your skin with our innovative photodynamic therapy medication.
Biofrontera AG is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical cosmetics.
The Germany-based company develops and markets innovative products for the care, protection and treatment of the skin. The company’s lead product is the combination of Ameluz®, a topical prescription drug, and medical device BF-RhodoLED® for the photodynamic therapy of certain superficial skin cancers and their precursors. Ameluz® has been marketed in the EU since 2012 and in the United States since May 2016. In the EU, the company also sells the dermocosmetics series Belixos®, which offers specialized care for damaged or diseased skin.
Biofrontera is the first German pharmaceutical company to receive a centralized European and a US approval for a drug developed in-house. The Biofrontera Group was founded in 1997 and is listed on the Frankfurt Stock Exchange (ticker symbol: B8F) and on the US NASDAQ (ticker symbol: BFRA).
Dermatology, Wirkkosmetik, and Photodynamic Therapy